Clinical Trials Browser

Phase 1/2 × Adenocarcinoma × Genistein × Clear all

NCT01182246 2014-04-23

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Phase 1/2 Unknown

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms